Bluschke, Annet
von der Hagen, Maja
Papenhagen, Katharina
Roessner, Veit
Beste, Christian
Article History
Received: 4 August 2016
Accepted: 1 February 2017
First Online: 6 March 2017
Competing interests
: A.B., M.v.d.H. and K.P. declare no competing or potential conflicts of interest. V.R. has received payment for consulting and writing activities from Lilly, Novartis, and Shire Pharmaceuticals, lecture honoraria from Lilly, Novartis, Shire Pharmaceuticals, and Medice Pharma, and support for research from Shire and Novartis. He has carried out (and is currently carrying out) clinical trials in cooperation with the Novartis, Shire, and Otsuka companies. C.B. has received payment for consulting from GlaxoSmithKline, and Teva.